BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8672987)

  • 1. Comparison of rectal mucosal proliferation measured by proliferating cell nuclear antigen (PCNA) immunohistochemistry and whole crypt dissection.
    Murray SC; Sandler RS; Keku TO; Lyles CM; Millikan RC; Bangdiwala SI; Kupper LL; Jiang W; Ulshen MH
    Cancer Epidemiol Biomarkers Prev; 1995; 4(7):715-20. PubMed ID: 8672987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal mucosal proliferation, dietary factors, and the risk of colorectal adenomas.
    Keku TO; Galanko JA; Murray SC; Woosley JT; Sandler RS
    Cancer Epidemiol Biomarkers Prev; 1998 Nov; 7(11):993-9. PubMed ID: 9829707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility and variability of the rectal mucosal proliferation index using proliferating cell nuclear antigen immunohistochemistry.
    Lyles CM; Sandler RS; Keku TO; Kupper LL; Millikan RC; Murray SC; Bangdiwala SI; Ulshen MH
    Cancer Epidemiol Biomarkers Prev; 1994; 3(7):597-605. PubMed ID: 7827591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methodological findings and considerations in measuring colorectal epithelial cell proliferation in humans.
    Bostick RM; Fosdick L; Lillemoe TJ; Overn P; Wood JR; Grambsch P; Elmer P; Potter JD
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):931-42. PubMed ID: 9367067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of incubation of rectal biopsies on measures of proliferation using proliferating cell nuclear antigen in comparison with 5-bromo-2-deoxyuridine.
    Kilias D; Macrae FA; Sharpe K; Young GP
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):819-24. PubMed ID: 9332765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of proliferating cell nuclear antigen in large intestinal crypt by computer-assisted image analysis.
    Lin HC; Sotnikov AV; Fosdick L; Bostick RM; Willett WC
    Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):109-14. PubMed ID: 8850271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of whole crypt mitotic count as a measure of cellular proliferation in rectal biopsies.
    Tosteson TD; Karagas MR; Rothstein R; Ahnen DJ; Greenberg ER
    Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):437-9. PubMed ID: 8781739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal mucosal proliferation and risk of colorectal adenomas: results from a randomized controlled trial.
    Sandler RS; Baron JA; Tosteson TD; Mandel JS; Haile RW
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):653-6. PubMed ID: 10919733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of proliferating cell nuclear antigen versus the more standard measures of rectal mucosal proliferation rates in subjects with a history of colorectal cancer and normal age-matched controls.
    Einspahr J; Alberts D; Xie T; Ritchie J; Earnest D; Hixson L; Powell M; Roe D; Grogan T
    Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):359-66. PubMed ID: 7655331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
    Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
    Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of milk and milk products on rectal mucosal cell proliferation in humans.
    Karagas MR; Tosteson TD; Greenberg ER; Rothstein RI; Roebuck BD; Herrin M; Ahnen D
    Cancer Epidemiol Biomarkers Prev; 1998 Sep; 7(9):757-66. PubMed ID: 9752983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological use of rectal proliferation measures.
    Baron JA; Wargovich MJ; Tosteson TD; Sandler R; Haile R; Summers R; van Stolk R; Rothstein R; Weiss J
    Cancer Epidemiol Biomarkers Prev; 1995; 4(1):57-61. PubMed ID: 7894325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evaluation of rectal mucosal proliferation measure variability sources in the polyp prevention trial: can we detect informative differences among individuals' proliferation measures amid the noise?
    McShane LM; Kulldorff M; Wargovich MJ; Woods C; Purewal M; Freedman LS; Corle DK; Burt RW; Mateski DJ; Lawson M; Lanza E; O'Brien B; Lake W; Moler J; Schatzkin A
    Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):605-12. PubMed ID: 9681529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methodological problems in the use of rectal cell proliferation as a biomarker of colorectal cancer risk.
    Biasco G; Paganelli GM; Santucci R; Brandi G; Barbara L
    J Cell Biochem Suppl; 1994; 19():55-60. PubMed ID: 7823606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferative patterns of rectal mucosa as predictors of advanced colonic neoplasms in routinely processed rectal biopsies.
    Paspatis GA; Zizi A; Chlouverakis GJ; Giannikaki ES; Vasilakaki T; Elemenoglou I; Karamanolis DG
    Am J Gastroenterol; 1998 Sep; 93(9):1472-7. PubMed ID: 9732928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromodeoxyuridine uptake and proliferating cell nuclear antigen expression throughout the colorectal tumor sequence.
    Risio M; Candelaresi G; Rossini FP
    Cancer Epidemiol Biomarkers Prev; 1993; 2(4):363-7. PubMed ID: 8102291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
    Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
    Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rectal epithelial cell proliferation: comparison of errors of measurement with inter-subject variance. Australian Polyp Prevention Project Investigators.
    Macrae FA; Kilias D; Sharpe K; Hughes N; Young GP; MacLennan R
    J Cell Biochem Suppl; 1994; 19():84-90. PubMed ID: 7823610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low dose aspirin (81 mg) on proliferating cell nuclear antigen and Amaranthus caudatus labeling in normal-risk and high-risk human subjects for colorectal cancer.
    Krishnan K; Aoki T; Ruffin MT; Normolle DP; Boland CR; Brenner DE
    Cancer Detect Prev; 2004; 28(2):107-13. PubMed ID: 15068834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsteroidal anti-inflammatory drugs, apoptosis, and colorectal adenomas.
    Martin C; Connelly A; Keku TO; Mountcastle SB; Galanko J; Woosley JT; Schliebe B; Lund PK; Sandler RS
    Gastroenterology; 2002 Dec; 123(6):1770-7. PubMed ID: 12454832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.